| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |